Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0Sales per Share
VS
Market
Sector
Industry
History
$ 0.68Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information
Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGT BIOPHARMA INC - Sales per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GTBP - SPS Historical data
| Date | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
|---|---|---|---|---|
| 6/30/2025 | $ 0 | 1 | 2.77M | $ 0 |
| 3/31/2025 | $ 0 | 1 | 2.35M | $ 0 |
| 12/31/2024 | $ 0 | 1 | 1.9M | $ 0 |
| 9/30/2024 | $ 0 | 1 | 2.23M | $ 0 |
| 6/30/2024 | $ 0 | 1 | 1.71M | $ 0 |
| 3/31/2024 | $ 0 | 1 | 1.38M | $ 0 |
| 12/31/2023 | $ 0 | 1 | 1.35M | $ 0 |
| 9/30/2023 | $ 0 | 1 | 1.37M | $ 0 |
| 6/30/2023 | $ 0 | 1 | 1.34M | $ 0 |
| 3/31/2023 | $ 0 | 1 | 1.3M | $ 0 |
Key Performance Insights, Last 5 Years
- GT BIOPHARMA INC's latest trailing twelve months (TTM) SPS stands at $ 0.
- Over the past 5 years, GT BIOPHARMA INC's average SPS has been $ 0.
- The median SPS for GT BIOPHARMA INC during this period was $ 0
- GT BIOPHARMA INC reached its highest SPS over the past 5 years at $ 0.
- The lowest SPS recorded by GT BIOPHARMA INC in the same timeframe $ 0
Similar metrics to SPS:
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Sales per Share
[Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Revenues / (Shares WA * Share Factor)
(=) SPS SPS for GT BIOPHARMA INC is calculated as follows: Revenues [ $ 0 ] / (Shares WA [ 150.45K ] * Share Factor [ 1 ])
(=) SPS [ $ 0 ] GTBP - Sales per Share, Last 5 years
$ 0
Minimum
Sep 30, 2020
$ 0
Maximum
Sep 30, 2020
$ 0
Average
$ 0
Median
SPS Benchmark AnalysisMarket
The chart above depicts the distribution of SPS for companies in the Total Stock Market. The average SPS of the companies is $ 11.54 with a standard deviation of $ 13.61.
The following table provides additional summary stats:
SPS in the Market:
| filtered constituents | 3.63K |
|---|---|
| min | $ -18.02 |
| max | $ 54.8 |
| average | $ 11.54 |
| median | $ 5.88 |
| std | $ 13.61 |